Study on Cases of Eclampsia: A Clinical Approach
DOI:
https://doi.org/10.9734/bpi/nfmmr/v2/2993FKeywords:
ARF, DIC, Eclampsia, magnesium toxicity, maternal mortality, PPH, pregnancy induced hypertensionAbstract
Background: Eclampsia is a life-threatening illness that is one of the most leading causes of maternal death around the world. Acute renal failure, DIC, postpartum haemorrhage, and other problems, as well as adverse foetal outcomes, are all linked to it.
Aims: This study aimed to highlights fetomaternal outcomes in cases of Eclampsia.
Methods: From January 1, 2016, to June 30, 2017, a total of 75 cases of eclampsia were assessed at RZ Hospital, a government tertiary referral centre. The complications of pregnancy, the efficiency of magnesium sulphate treatment, the foetal outcome, and the route of delivery were all investigated.
Results: Eclampsia had a 0.55 percent incidence rate, with 62.66 percent of all cases being primigravida, 76 percent of cases being between the ages of 21 and 26, 84 percent of cases being from lower socioeconomic position, and maternal mortality occurring in two of every 75 cases. 66.67 percent of patients were pregnant to term (37 to 42 weeks).71 percent (53) of patients delivered vaginally, with 9 spontaneous deliveries and 44 induced vaginal deliveries. 22 patients required caesarean section.
Conclusions: Early detection and prevention of pregnancy-induced hypertension and pre-eclampsia, as well as other eclampsia risk factors, may assist to lower the occurrence of the condition. Magnesium toxicity, acute renal failure (ARF), disseminated intravascular coagulation (DIC), and postpartum haemorrhage (PPH) were the maternal unfavourable events in this trial, with 92 percent of women having no problems.
